Category: Boston Scientific
Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific loses $309 million judgment in Mirowski patent war; Ex-Advanced Medical Optics CEO Mazzo indicted in insider trading case; Appeals court denies BD bid to revisit loss to Retractable Technologies; Ackman threatens to sue Allergan again over potential Salix deal; Judge upholds $30M infringement ruling against NuVasive, cancels trademark
Abbott Medical Optics
, AcuFocus Inc.
, Advanced Medical Optics
, Becton Dickinson & Co.
, Boston Scientific
, Mirowski Family Ventures
, NeuroVision Medical Products Inc.
, Pershing Square Capital Management
, Retractable Technologies Inc.
, St. Jude Medical
, Valeant Pharmaceuticals
, Versant Ventures
, Allergan Inc.
Despite Boston Scientific having yet to debut a pacemaker that nestles inside the heart itself, an analyst said the company may be best positioned to capitalize on sales of such devices.
Boston Scientific loses a $309 million judgment in its long-running patent war with Mirowski Family ventures over cardiac pacemaker technology.
UPDATED Sept. 25, 2014, with comment from Boston Scientific.
Boston Scientific launches a U.S. clinical trial of its Lotus transcatheter aortic valve implant in high-and extreme-risk patients.
Here's a look at some of the top regulatory stories for medical device companies this week: Boston Scientific wins CE Mark for Vercise brain stim device; 20 Years of Improving Women's Health; Medtronic wins CE Mark for Tyrx cardiac device envelope; VertiFlex lands FDA panel date for Superion interspinous spacer
New data presented last week at the annual Transcatheter Cardiovascular Therapies meeting showed Boston Scienfitic's Watchman anti-stoke device to be comparable to treatment with the anti-coagulant warfarin.
Here's a look at some of the top legal news stories for medical device companies this week: Another J&J exec pressed in lawsuit over Pinnacle hip implant; Did Boston Scientific lose $74M mesh trial over an email?; Boston Scientific must face trial in spat over stent patents; Allergan pushes to kick Valeant, Pershing out of special shareholder meeting; Medtronic settles CRM kickbacks case with final, $362k payment